Advertisement

Stimulus Dependent Phenotypic Diversity in the Resistant Hepatocyte Model

  • M. R. Alison
  • J. R. Hully

Abstract

In the liver, hepatocytes recently initiated by chemical carcinogens show little outward sign of change (e.g. autonomy of growth). Almost all chemical carcinogens are cytotoxic in some way and one facet of this cytotoxicity can be an inhibition of cell proliferationl. Thus the acquisition of resistance to the cytotoxicity of a carcinogen by initiated cells offers an opportunity for such cells to gain a proliferative advantage over normal cells in an adverse environment. The basis for such resistance could be an alteration in the uptake, metabolism or excretion of the carcinogen2.

Keywords

Partial Hepatectomy Cyproterone Acetate Portal Vein Ligation Basophilic Cell Mitogenic Stimulus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. Haddow, Influence of certain polycyclic hydrocarbons on the growth of the Jensen rat sarcoma, Nature, Lond. 136: 868 (1935).CrossRefGoogle Scholar
  2. 2.
    E. Farber, The biochemistry of preneoplastic liver: a common metabolic pattern in hepatocyte nodules, Can. J. Biochem. Cell Biol. 62:486 (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    D. B. Solt, A. Medline, and E. Farber, Rapid emergence of carcinogen induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis, Am. J. Pathol. 88:595 (1977).PubMedGoogle Scholar
  4. 4.
    H. M. Rabes, Th. Bucher, A. Hartmann, I. Linke, and M. Dunnwald, Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver, Cancer Res. 42: 3220 (1982).PubMedGoogle Scholar
  5. 5.
    M. R. Alison, C. J. Ryan, C. A. Lee, and K. McDermott, Compensatory hyperplasia in the rat liver as a result of cytoplasmic atrophy, Br. J. Exp. Path. 67:901 (1986).Google Scholar
  6. 6.
    R. Schulte-Hermann, and W. Parzefall, Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers.I. Induction of drug-metabolizing enzymes, Chem.-Biol. Interactions 31:279 (1980).CrossRefGoogle Scholar
  7. 7.
    W. Bursch, H. S. Taper, B. Lauer, and R. Schulte-Hermann, Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia, Virchows Arch.(Cell Pathol) 50: 153 (1985).CrossRefGoogle Scholar
  8. 8.
    W. Bursch, B. Dusterberg, and R. Schulte-Hermann, Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate, Arch. Toxicol. 59:221 (1986).PubMedCrossRefGoogle Scholar
  9. 9.
    M. R. Alison, M. J. E. Wilkins, S. M. Walker, and J. R. Hully, Cell population size control in the rat liver: the response of hepatocytes in various proliferative states to a mitogenic stimulus, Epithelia 1: 53 (1987).Google Scholar
  10. 10.
    P. Bannasch, D. Mayer, and H. J. Hacker, Hepatocellular glycogenosis and hepatocarcinogenesis, Biochim. Biophys. Acta, 605:217 (1980).PubMedGoogle Scholar
  11. 11.
    P. Bannasch, H. J. Hacker, F. Klimek, and D. Mayer, Hepatocellular glycogenosis and related pattern of enzymic changes during hepatocarcinogenesis, Adv. Enzyme Requl. 22:97 (1984).CrossRefGoogle Scholar
  12. 12.
    M. A. Moore, and T. Kitagawa, Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro, Int. Rev. Cytol. 101:125 (1986).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • M. R. Alison
    • 1
  • J. R. Hully
    • 2
  1. 1.Department of HistopathologyRoyal Postgraduate Medical SchoolLondonUK
  2. 2.Laboratory for Cancer ResearchUniversity of WisconsinMadisonUSA

Personalised recommendations